1. Market Research
  2. > Healthcare
  3. > Medical Device Market Trends
  4. > Canada Cardiovascular Devices Market Outlook to 2020

Canada Cardiovascular Devices Market Outlook to 2020

  • May 2014
  • -
  • Global Data
  • -
  • 247 pages

Canada Cardiovascular Devices Market Outlook to 2020

Summary

GlobalData’s new report, "Canada Cardiovascular Devices Market Outlook to 2020", provides key market data on the Canada Cardiovascular Devices market. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market categories - Cardiac Assist Devices, Cardiac Rhythm Management Devices, Cardiovascular Monitoring and Diagnostic Devices, Cardiovascular Prosthetic Devices, Cardiovascular Surgery Devices, Electrophysiology Devices, External Defibrillators, Interventional Cardiology, Peripheral Vascular Devices and Prosthetic Heart Valves.

The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Cardiovascular Devices market wherever available.

The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible.

The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers.

Capital equipment-based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Data for average number of units per facility is used to arrive at the installed base of the capital equipment. Sales for a particular year are arrived at by calculating the replacement units and new units (additional and first-time purchases).

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

- Market size and company share data for Cardiovascular Devices categories - Cardiac Assist Devices, Cardiac Rhythm Management Devices, Cardiovascular Monitoring and Diagnostic Devices, Cardiovascular Prosthetic Devices, Cardiovascular Surgery Devices, Electrophysiology Devices, External Defibrillators, Interventional Cardiology, Peripheral Vascular Devices and Prosthetic Heart Valves.
- Annualized market revenues (USD million) and volume (units) data for each of the market categories. Data is provided from 2005 to 2012 and forecast to 2020.
- 2012 company shares and distribution shares data for each of the market categories.
- Global corporate-level profiles of key companies operating within the Canada Cardiovascular Devices market.
- Key players covered include Medtronic, Inc., Boston Scientific Corporation, St. Jude Medical, Inc., Abbott Laboratories, Cordis Corporation, C.R. Bard, Inc., Thoratec Corporation, Philips Healthcare, Sorin Group, MAQUET GmbH & Co. KG, Edwards Lifesciences Corporation, Terumo Corporation and BIOTRONIK SE & Co. KG.

Reasons to buy

- Develop business strategies by identifying the key market categories and segments poised for strong growth in the future.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the market.
- Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.

Table Of Contents

Canada Cardiovascular Devices Market Outlook to 2020
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 8
1.2 List of Figures 10
2 Introduction 13
2.1 What Is This Report About? 13
2.2 Cardiovascular Devices Market Segmentation 13
2.3 Definitions of Markets Covered in the Report 16
3 Cardiovascular Devices Market, Canada 32
3.1 Cardiovascular Devices Market, Canada, Revenue ($m), 2005-2020 32
3.2 Cardiovascular Devices Market, Canada, Revenue Mix ($m), 2012 34
3.3 Cardiovascular Devices Market, Canada, Category Contribution by Revenue ($m), 2012 35
3.4 Cardiovascular Devices Market, Canada, Category Comparison by Revenue ($m), 2005-2020 37
3.5 Cardiovascular Devices Market, Canada, Revenue ($m), 2005-2012 39
3.6 Cardiovascular Devices Market, Canada, Revenue ($m), 2012-2020 41
3.7 Cardiovascular Devices Market, Canada, Volume (Units), 2005-2020 43
3.8 Cardiovascular Devices Market, Canada, Volume (Units), 2005-2012 45
3.9 Cardiovascular Devices Market, Canada, Volume (Units), 2012-2020 47
3.10 Cardiovascular Devices Market, Canada, Company Share by Revenue ($m), 2011-2012 50
4 Cardiac Assist Devices Market, Canada 52
4.1 Cardiac Assist Devices Market, Canada, Revenue Mix ($m), 2012 52
4.2 Cardiac Assist Devices Market, Canada, Segment Contribution (%), 2012 53
4.3 Cardiac Assist Devices Market, Canada, Revenue ($m), by Segment, 2005-2012 54
4.4 Cardiac Assist Devices Market, Canada, Revenue ($m) by Segment, 2012-2020 56
4.5 Cardiac Assist Devices Market, Canada, Volume (Units) by Segment, 2005-2012 58
4.6 Cardiac Assist Devices Market, Canada, Volume (Units) by Segment, 2012-2020 60
4.7 Cardiac Assist Devices Market, Canada, Distribution Share, Revenue ($m), 2011-2012 62
4.8 Cardiac Assist Devices Market, Canada, Company Share by Revenue ($m), 2011-2012 63
5 Cardiac Rhythm Management Market, Canada 65
5.1 Cardiac Rhythm Management Market, Canada, Revenue Mix ($m), 2012 65
5.2 Cardiac Rhythm Management Market, Canada, Segment Contribution (%), 2012 66
5.3 Cardiac Rhythm Management Market, Canada, Revenue ($m), by Segment, 2005-2012 67
5.4 Cardiac Rhythm Management Market, Canada, Revenue ($m) by Segment, 2012-2020 69
5.5 Cardiac Rhythm Management Market, Canada, Volume (Units) by Segment, 2005-2012 71
5.6 Cardiac Rhythm Management Market, Canada, Volume (Units) by Segment, 2012-2020 73
5.7 Cardiac Rhythm Management Market, Canada, Distribution Share, Revenue ($m), 2011-2012 75
5.8 Cardiac Rhythm Management Market, Canada, Company Share by Revenue ($m), 2011-2012 76
6 Cardiovascular Monitoring and Diagnostic Devices Market, Canada 78
6.1 Cardiovascular Monitoring and Diagnostic Devices Market, Canada, Revenue ($m), by Segment, 2005-2012 78
6.4 Cardiovascular Monitoring and Diagnostic Devices Market, Canada, Revenue ($m) by Segment, 2012-2020 80
6.5 Cardiovascular Monitoring and Diagnostic Devices Market, Canada, Volume (Units) by Segment, 2005-2012 82
6.6 Cardiovascular Monitoring and Diagnostic Devices Market, Canada, Volume (Units) by Segment, 2012-2020 83
6.7 Cardiovascular Monitoring and Diagnostic Devices Market, Canada, Distribution Share, Revenue ($m), 2011-2012 84
6.8 Cardiovascular Monitoring and Diagnostic Devices Market, Canada, Company Share by Revenue ($m), 2011-2012 85
7 Cardiovascular Prosthetic Devices Market, Canada 87
7.1 Cardiovascular Prosthetic Devices Market, Canada, Revenue Mix ($m), 2012 87
7.2 Cardiovascular Prosthetic Devices Market, Canada, Segment Contribution (%), 2012 88
7.3 Cardiovascular Prosthetic Devices Market, Canada, Revenue ($m), by Segment, 2005-2012 89
7.4 Cardiovascular Prosthetic Devices Market, Canada, Revenue ($m) by Segment, 2012-2020 91
7.5 Cardiovascular Prosthetic Devices Market, Canada, Volume (Units) by Segment, 2005-2012 93
7.6 Cardiovascular Prosthetic Devices Market, Canada, Volume (Units) by Segment, 2012-2020 95
7.7 Cardiovascular Prosthetic Devices Market, Canada, Distribution Share, Revenue ($m), 2011-2012 97
7.8 Cardiovascular Prosthetic Devices Market, Canada, Company Share by Revenue ($m), 2011-2012 98
8 Cardiovascular Surgery Market, Canada 100
8.1 Cardiovascular Surgery Market, Canada, Revenue Mix ($m), 2012 100
8.2 Cardiovascular Surgery Market, Canada, Segment Contribution (%), 2012 101
8.3 Cardiovascular Surgery Market, Canada, Revenue ($m), by Segment, 2005-2012 102
8.4 Cardiovascular Surgery Market, Canada, Revenue ($m) by Segment, 2012-2020 104
8.5 Cardiovascular Surgery Market, Canada, Volume (Units) by Segment, 2005-2012 106
8.6 Cardiovascular Surgery Market, Canada, Volume (Units) by Segment, 2012-2020 108
8.7 Cardiovascular Surgery Market, Canada, Distribution Share, Revenue ($m), 2011-2012 110
8.8 Cardiovascular Surgery Market, Canada, Company Share by Revenue ($m), 2011-2012 111
9 Electrophysiology Market, Canada 113
9.1 Electrophysiology Market, Canada, Revenue Mix ($m), 2012 113
9.2 Electrophysiology Market, Canada, Segment Contribution (%), 2012 114
9.3 Electrophysiology Market, Canada, Revenue ($m), by Segment, 2005-2012 115
9.4 Electrophysiology Market, Canada, Revenue ($m) by Segment, 2012-2020 117
9.5 Electrophysiology Market, Canada, Volume (Units) by Segment, 2005-2012 119
9.6 Electrophysiology Market, Canada, Volume (Units) by Segment, 2012-2020 121
9.7 Electrophysiology Market, Canada, Distribution Share, Revenue ($m), 2011-2012 123
9.8 Electrophysiology Market, Canada, Company Share by Revenue ($m), 2011-2012 124
10 External Defibrillators Market, Canada 126
10.1 External Defibrillators Market, Canada, Revenue ($m), 2005-2012 126
10.2 External Defibrillators Market, Canada, Revenue ($m), 2012-2020 127
10.3 External Defibrillators Market, Canada, Volume (Units), 2005-2012 128
10.4 External Defibrillators Market, Canada, Volume (Units), 2012-2020 129
10.5 External Defibrillators Market, Canada, Distribution Share, Revenue ($m), 2011-2012 130
10.6 External Defibrillators Market, Canada, Company Share by Revenue ($m), 2011-2012 131
11 Interventional Cardiology Market, Canada 133
11.1 Interventional Cardiology Market, Canada, Revenue Mix ($m), 2012 133
11.2 Interventional Cardiology Market, Canada, Segment Contribution (%), 2012 134
11.3 Interventional Cardiology Market, Canada, Revenue ($m), by Segment, 2005-2012 135
11.4 Interventional Cardiology Market, Canada, Revenue ($m) by Segment, 2012-2020 137
11.5 Interventional Cardiology Market, Canada, Volume (Units) by Segment, 2005-2012 139
11.6 Interventional Cardiology Market, Canada, Volume (Units) by Segment, 2012-2020 141
11.7 Interventional Cardiology Market, Canada, Distribution Share, Revenue ($m), 2011-2012 143
11.8 Interventional Cardiology Market, Canada, Company Share by Revenue ($m), 2011-2012 144
12 Peripheral Vascular Devices Market, Canada 146
12.1 Peripheral Vascular Devices Market, Canada, Revenue Mix ($m), 2012 146
12.2 Peripheral Vascular Devices Market, Canada, Segment Contribution (%), 2012 147
12.3 Peripheral Vascular Devices Market, Canada, Revenue ($m), by Segment, 2005-2012 149
12.4 Peripheral Vascular Devices Market, Canada, Revenue ($m) by Segment, 2012-2020 151
12.5 Peripheral Vascular Devices Market, Canada, Volume (Units) by Segment, 2005-2012 153
12.6 Peripheral Vascular Devices Market, Canada, Volume (Units) by Segment, 2012-2020 155
12.7 Peripheral Vascular Devices Market, Canada, Distribution Share, Revenue ($m), 2011-2012 157
12.8 Peripheral Vascular Devices Market, Canada, Company Share by Revenue ($m), 2011-2012 158
13 Prosthetic Heart Valves Market, Canada 160
13.1 Prosthetic Heart Valves Market, Canada, Revenue Mix ($m), 2012 160
13.2 Prosthetic Heart Valves Market, Canada, Segment Contribution (%), 2012 161
13.3 Prosthetic Heart Valves Market, Canada, Revenue ($m), by Segment, 2005-2012 162
13.4 Prosthetic Heart Valves Market, Canada, Revenue ($m) by Segment, 2012-2020 164
13.5 Prosthetic Heart Valves Market, Canada, Volume (Units) by Segment, 2005-2012 166
13.6 Prosthetic Heart Valves Market, Canada, Volume (Units) by Segment, 2012-2020 168
13.7 Prosthetic Heart Valves Market, Canada, Distribution Share, Revenue ($m), 2011-2012 170
13.8 Prosthetic Heart Valves Market, Canada, Company Share by Revenue ($m), 2011-2012 171
14 Overview of Key Companies in Canada, Cardiovascular Devices Market 173
14.1 Medtronic, Inc. 173
14.1.1 Company Overview 173
14.2 Boston Scientific Corporation 173
14.2.1 Company Overview 173
14.3 St. Jude Medical, Inc. 173
14.3.1 Company Overview 173
14.4 Abbott Laboratories 174
14.4.1 Company Overview 174
14.5 Edwards Lifesciences Corporation 174
14.5.1 Company Overview 174
14.6 Cordis Corporation 174
14.6.1 Company Overview 174
14.7 C. R. Bard, Inc. 175
14.7.1 Company Overview 175
14.8 Sorin S.p.A. 175
14.8.1 Company Overview 175
14.9 Thoratec Corporation 175
14.9.1 Company Overview 175
14.10 Maquet Holding B.V. and Co. KG. 175
14.10.1 Company Overview 175
14.11 Biosense Webster, Inc. 176
14.11.1 Company Overview 176
14.12 Biotronik SE and Co. KG 176
14.12.1 Company Overview 176
14.13 Philips Healthcare 176
14.13.1 Company Overview 176
14.14 Terumo Corporation 177
14.14.1 Company Overview 177
14.15 Covidien plc 177
14.15.1 Company Overview 177
14.16 Zoll Medical Corporation 177
14.16.1 Company Overview 177
15 Cardiovascular Devices Market Pipeline Products 178
16 Financial Deals Landscape 180
16.1 Asset Transactions 180
16.1.1 AngioDynamics Completes Acquisition Of Rights To Microwave Ablation Technology For US$16 Million 180
16.1.2 LeMaitre Vascular Finalizes Acquisition of XenoSure From Neovasc For US$5 Million 182
16.2 Equity Offerings 184
16.2.1 Neovasc Files Registration Statement For Public Offering Of Securities For Up To US$200 Million 184
16.2.2 Neovasc Completes Public Offering Of Shares For US$22.7 Million 185
16.2.3 CardioComm Solutions Completes First Tranche Of Private Placement For US$0.1 Millon 186
16.2.4 Neovasc Completes Private Placement Of Shares For US$2.2 Million Upon Exercise Of Warrants 187
16.3 Partnerships 189
16.3.1 Abiomed Enters Into Licensing Agreement With Opsens For Optical Sensor Technology 189
16.3.2 QHR Technologies Enters Into Agreement With Welch Allyn For Cardiopulmonary Devices 190
16.3.3 Interface Biologics To Enter Into Co-Development Agreement With Qualimed Innovative Medizinprodukte 191
16.3.4 Koninklijke Royal Philips And Infraredx Enter Into Agreement For Imaging System And X-ray Systems 192
16.3.5 Xenios Enters Into Licensing Agreement With Leukocare For Next Generation Extracorporeal Support Systems 193
16.3.6 AngioDynamics Extends Licensing Agreement With Interface Biologics To Include Central Venous Catheters 194
16.3.7 Terumo Enters Into Co-Development Agreement With Kaneka For PTA Balloon Catheters 196
16.3.8 Terumo Enters Into Agreement With Shanghai AngioCare Medical Technolgy 197
16.3.9 NeoChord Enters Into Licensing Agreement With Robarts Research Institute 198
16.3.10 Biosensors Extends Licensing Agreement With Terumo For BioMatrix Technology 199
16.4 Venture Financing 200
16.4.1 CellAegis Devices Raises Funds Through Venture Financing 200
16.4.2 CellAegis Devices Raises US$0.02 Million In Venture Financing 201
17 Recent Developments 202
17.1 Corporate Communications 202
17.1.1 Apr 17, 2014: Neovasc Reports Financial Results For 2013 202
17.1.2 Apr 17, 2014: Neovasc announces filing of shelf prospectus and application to list on NASDAQ 204
17.1.3 Oct 11, 2013: Angiotech Announces Changes to Management and Board of Directors 204
17.1.4 Sep 19, 2013: IMRIS Announces Addition of Dr. Vipul Patel to SYMBIS Advisory Board 205
17.1.5 Aug 15, 2013: R. Stephen Armstrong Joins IMRIS Board of Directors 205
17.1.6 Jul 29, 2013: Jay D. Miller Appointed Chief Executive Officer 206
17.1.7 May 15, 2013: Results of Comparative Study between Epigenomics Epi proColon and FIT to be Presented at Digestive Disease Week 206
17.2 Financial Announcements 208
17.2.1 Mar 25, 2014: IBEX Reports Results for the Second Quarter and the Six Months Ended January 31, 2014 208
17.2.2 Mar 21, 2014: Angiotech Pharmaceuticals announces 2013 financial results and provides update on recent developments 208
17.2.3 Mar 04, 2014: IMRIS Reports Fourth Quarter and Annual 2011 Financial Results 210
17.2.4 Feb 06, 2014: NOVADAQ Reports 2013 Fourth Quarter and Full Year Financial Results 212
17.2.5 Jan 14, 2014: Novadaq Announces Fourth Quarter 2013 Preliminary Unaudited Revenues 213
17.2.6 Dec 19, 2013: IBEX Reports First Quarter Fiscal 2014 Results 213
17.2.7 Nov 29, 2013: IBEX Reports Results for the Year Ended July 31, 2013 214
17.2.8 Nov 20, 2013: Neovasc Reports Financial Results for Third Quarter of 2013 215
17.2.9 Nov 04, 2013: IMRIS Reports Third Quarter 2013 Financial Results 217
17.2.10 Oct 22, 2013: Novadaq Reports Third Quarter 2013 Financial Results 219
17.2.11 Oct 10, 2013: Novadaq to Release Third Quarter 2013 Financial Results on October 22, 2013-Conference Call to Follow 220
17.2.12 Sep 13, 2013: IBEX Reports Expected Significant Decrease in Fiscal 2014 Earnings 220
17.2.13 Aug 13, 2013: IMRIS reports second quarter 2013 financial results 220
17.2.14 Aug 01, 2013: Novadaq Reports Second Quarter 2013 Financial Results 222
17.2.15 Jul 25, 2013: Angiotech Announces Conference Call and Webcast of Second Quarter 2013 Results 224
17.2.16 Jul 18, 2013: Novadaq to Release Second Quarter 2013 Financial Results on August 1, 2013 - Conference Call to Follow 224
17.2.17 Jun 27, 2013: IBEX Reports Results for the Third Quarter and the Nine Months Ended April 30, 2013 224
17.2.18 May 28, 2013: Neovasc Reports Revenue Of CAD2m In Q1 2013 225
17.2.19 May 02, 2013: Imris Reports Revenue Of $8.1m In Q1 2013 228
17.2.20 Apr 29, 2013: Novadaq Reports Revenue Of $7.3m In Q1 2013 229
17.2.21 Apr 22, 2013: Novadaq to Release First Quarter 2013 Financial Results on April 29, 2013 - Conference Call to Follow 230
17.3 Government and Public Interest 230
17.3.1 Dec 10, 2013: Novadaq to Present at January Investor Conferences 230
17.3.2 Nov 25, 2013: Novadaq to Present at December Investor Healthcare Events 231
17.3.3 Nov 13, 2013: IMRIS to present at Investor Healthcare Conferences in New York 231
17.3.4 Nov 04, 2013: Novadaq to Present at November Investor Healthcare Conferences 231
17.3.5 Aug 29, 2013: Novadaq to Present at the Stifel Healthcare Conference 2013 231
17.3.6 Aug 09, 2013: IMRIS CEO Jay D. Miller to present at Canaccord Genuity 33rd Annual Global Growth Conference 232
17.4 Other Significant Developments 232
17.4.1 Jan 02, 2014: Response Biomedical Provides Update on Chinese Distribution Agreement with OandD Biotech 232
17.4.2 Nov 07, 2013: Novadaq and Swissray Asia Announce International SPY and PINPOINT Distribution Agreements 232
17.4.3 Sep 18, 2013: Novadaq to Host Investor Meeting on November 18, 2013 233
17.5 Product News 233
17.5.1 Nov 25, 2013: Cardiocomm Solutions Completes Mobile Cardiac Telemetry Software Release for Raytel Cardiac Services 233
17.5.2 Nov 13, 2013: Neovasc receives first US patent for its novel Tiara transcatheter mitral valve replacement technology 234
17.5.3 Oct 10, 2013: CardioComm Solutions' HeartCheck Technologies to be used in Canadian Clinical Arrhythmia Risk Screening and Stoke Prevention Trial 234
17.5.4 Jul 23, 2013: Automated ECG directs patients with acute MI to cath lab 235
17.5.5 May 09, 2013: CardioComm Solutions Files US And Canadian Patents For OTC And Bio-Monitoring Devices 236
17.5.6 Apr 24, 2013: CardioComm Expands Smart Monitoring Service And Infrastructure To Meet Consumer Demand For Faster ECG Interpretation Services 237
17.6 Strategy And Business Planning 238
17.6.1 Jul 30, 2013: Argon Medical To Close Plant, Eliminates 111 Jobs 238
18 Appendix 239
18.1 Research Methodology 240
18.1.1 Coverage 240
18.1.2 Secondary Research 240
18.1.3 Primary Research 241
18.1.4 Market Modeling and Forecasting 242
18.1.5 Company Share Analysis 245
18.1.6 Distribution Share Analysis 246
18.2 Expert Panel 246
18.3 GlobalData Consulting 247
18.4 Contact Us 247
18.5 Disclaimer 247

1.1 List of Tables
Table 1: Cardiovascular Devices Market, Canada, Revenue ($m), USD Constant, 2005-2020 33
Table 2: Cardiovascular Devices Market, Canada, Category Contribution by Revenue ($m), 2012 36
Table 3: Cardiovascular Devices Market, Canada, Category Comparison by Revenue ($m), 2005-2020 38
Table 4: Cardiovascular Devices Market, Canada, Revenue ($m), USD Constant, Historic, 2005-2012 40
Table 5: Cardiovascular Devices Market, Canada, Revenue ($m), USD Constant, Forecast, 2012-2020 42
Table 6: Cardiovascular Devices Market, Canada, Volume (Units), 2005-2020 44
Table 7: Cardiovascular Devices Market, Canada, Volume (Units), Historic, 2005-2012 46
Table 8: Cardiovascular Devices Market, Canada, Volume (Units), Forecast, 2012-2020 48
Table 9: Cardiovascular Devices Market, Canada, Company Share by Revenue ($m), USD Constant, 2011-2012 51
Table 10: Cardiac Assist Devices Market, Canada, Segment Contribution (%), 2012 53
Table 11: Cardiac Assist Devices Market, Canada, Revenue ($m), USD Constant, Historic, 2005-2012 55
Table 12: Cardiac Assist Devices Market, Canada, Revenue ($m) USD Constant, Forecast, 2012-2020 57
Table 13: Cardiac Assist Devices Market, Canada, Volume (Units), Historic, 2005-2012 59
Table 14: Cardiac Assist Devices Market, Canada, Volume (Units), Forecast, 2012-2020 61
Table 15: Cardiac Assist Devices Market, Canada, Distribution Share by Revenue ($m), USD Constant, 2011-2012 62
Table 16: Cardiac Assist Devices Market, Canada, Company Share by Revenue ($m), USD Constant, 2011-2012 64
Table 17: Cardiac Rhythm Management Market, Canada, Segment Contribution (%), 2012 66
Table 18: Cardiac Rhythm Management Market, Canada, Revenue ($m), USD Constant, Historic, 2005-2012 68
Table 19: Cardiac Rhythm Management Market, Canada, Revenue ($m) USD Constant, Forecast, 2012-2020 70
Table 20: Cardiac Rhythm Management Market, Canada, Volume (Units), Historic, 2005-2012 72
Table 21: Cardiac Rhythm Management Market, Canada, Volume (Units), Forecast, 2012-2020 74
Table 22: Cardiac Rhythm Management Market, Canada, Distribution Share by Revenue ($m), USD Constant, 2011-2012 75
Table 23: Cardiac Rhythm Management Market, Canada, Company Share by Revenue ($m), USD Constant, 2011-2012 77
Table 24: Cardiovascular Monitoring and Diagnostic Devices Market, Canada, Revenue ($m), USD Constant, Historic, 2005-2012 79
Table 25: Cardiovascular Monitoring and Diagnostic Devices Market, Canada, Revenue ($m) USD Constant, Forecast, 2012-2020 81
Table 26: Cardiovascular Monitoring and Diagnostic Devices Market, Canada, Volume (Units), Historic, 2005-2012 82
Table 27: Cardiovascular Monitoring and Diagnostic Devices Market, Canada, Volume (Units), Forecast, 2012-2020 83
Table 28: Cardiovascular Monitoring and Diagnostic Devices Market, Canada, Distribution Share by Revenue ($m), USD Constant, 2011-2012 84
Table 29: Cardiovascular Monitoring and Diagnostic Devices Market, Canada, Company Share by Revenue ($m), USD Constant, 2011-2012 86
Table 30: Cardiovascular Prosthetic Devices Market, Canada, Segment Contribution (%), 2012 88
Table 31: Cardiovascular Prosthetic Devices Market, Canada, Revenue ($m), USD Constant, Historic, 2005-2012 90
Table 32: Cardiovascular Prosthetic Devices Market, Canada, Revenue ($m) USD Constant, Forecast, 2012-2020 92
Table 33: Cardiovascular Prosthetic Devices Market, Canada, Volume (Units), Historic, 2005-2012 94
Table 34: Cardiovascular Prosthetic Devices Market, Canada, Volume (Units), Forecast, 2012-2020 96
Table 35: Cardiovascular Prosthetic Devices Market, Canada, Distribution Share by Revenue ($m), USD Constant, 2011-2012 97
Table 36: Cardiovascular Prosthetic Devices Market, Canada, Company Share by Revenue ($m), USD Constant, 2011-2012 99
Table 37: Cardiovascular Surgery Market, Canada, Segment Contribution (%), 2012 101
Table 38: Cardiovascular Surgery Market, Canada, Revenue ($m), USD Constant, Historic, 2005-2012 103
Table 39: Cardiovascular Surgery Market, Canada, Revenue ($m) USD Constant, Forecast, 2012-2020 105
Table 40: Cardiovascular Surgery Market, Canada, Volume (Units), Historic, 2005-2012 107
Table 41: Cardiovascular Surgery Market, Canada, Volume (Units), Forecast, 2012-2020 109
Table 42: Cardiovascular Surgery Market, Canada, Distribution Share by Revenue ($m), USD Constant, 2011-2012 110
Table 43: Cardiovascular Surgery Market, Canada, Company Share by Revenue ($m), USD Constant, 2011-2012 112
Table 44: Electrophysiology Market, Canada, Segment Contribution (%), 2012 114
Table 45: Electrophysiology Market, Canada, Revenue ($m), USD Constant, Historic, 2005-2012 116
Table 46: Electrophysiology Market, Canada, Revenue ($m) USD Constant, Forecast, 2012-2020 118
Table 47: Electrophysiology Market, Canada, Volume (Units), Historic, 2005-2012 120
Table 48: Electrophysiology Market, Canada, Volume (Units), Forecast, 2012-2020 122
Table 49: Electrophysiology Market, Canada, Distribution Share by Revenue ($m), USD Constant, 2011-2012 123
Table 50: Electrophysiology Market, Canada, Company Share by Revenue ($m), USD Constant, 2011-2012 125
Table 51: External Defibrillators Market, Canada, Revenue ($m), USD Constant, Historic, 2005-2012 126
Table 52: External Defibrillators Market, Canada, Revenue ($m) USD Constant, Forecast, 2012-2020 127
Table 53: External Defibrillators Market, Canada, Volume (Units), Historic, 2005-2012 128
Table 54: External Defibrillators Market, Canada, Volume (Units), Forecast, 2012-2020 129
Table 55: External Defibrillators Market, Canada, Distribution Share by Revenue ($m), USD Constant, 2011-2012 130
Table 56: External Defibrillators Market, Canada, Company Share by Revenue ($m), USD Constant, 2011-2012 132
Table 57: Interventional Cardiology Market, Canada, Segment Contribution (%), 2012 134
Table 58: Interventional Cardiology Market, Canada, Revenue ($m), USD Constant, Historic, 2005-2012 136
Table 59: Interventional Cardiology Market, Canada, Revenue ($m) USD Constant, Forecast, 2012-2020 138
Table 60: Interventional Cardiology Market, Canada, Volume (Units), Historic, 2005-2012 140
Table 61: Interventional Cardiology Market, Canada, Volume (Units), Forecast, 2012-2020 142
Table 62: Interventional Cardiology Market, Canada, Distribution Share by Revenue ($m), USD Constant, 2011-2012 143
Table 63: Interventional Cardiology Market, Canada, Company Share by Revenue ($m), USD Constant, 2011-2012 145
Table 64: Peripheral Vascular Devices Market, Canada, Segment Contribution (%), 2012 148
Table 65: Peripheral Vascular Devices Market, Canada, Revenue ($m), USD Constant, Historic, 2005-2012 150
Table 66: Peripheral Vascular Devices Market, Canada, Revenue ($m) USD Constant, Forecast, 2012-2020 152
Table 67: Peripheral Vascular Devices Market, Canada, Volume (Units), Historic, 2005-2012 154
Table 68: Peripheral Vascular Devices Market, Canada, Volume (Units), Forecast, 2012-2020 156
Table 69: Peripheral Vascular Devices Market, Canada, Distribution Share by Revenue ($m), USD Constant, 2011-2012 157
Table 70: Peripheral Vascular Devices Market, Canada, Company Share by Revenue ($m), USD Constant, 2011-2012 159
Table 71: Prosthetic Heart Valves Market, Canada, Segment Contribution (%), 2012 161
Table 72: Prosthetic Heart Valves Market, Canada, Revenue ($m), USD Constant, Historic, 2005-2012 163
Table 73: Prosthetic Heart Valves Market, Canada, Revenue ($m) USD Constant, Forecast, 2012-2020 165
Table 74: Prosthetic Heart Valves Market, Canada, Volume (Units), Historic, 2005-2012 167
Table 75: Prosthetic Heart Valves Market, Canada, Volume (Units), Forecast, 2012-2020 169
Table 76: Prosthetic Heart Valves Market, Canada, Distribution Share by Revenue ($m), USD Constant, 2011-2012 170
Table 77: Prosthetic Heart Valves Market, Canada, Company Share by Revenue ($m), USD Constant, 2011-2012 172
Table 78: Cardiovascular Devices Market Pipeline Products 178
Table 79: AngioDynamics Completes Acquisition Of Rights To Microwave Ablation Technology For US$16 Million 180
Table 80: LeMaitre Vascular Finalizes Acquisition of XenoSure From Neovasc For US$5 Million 182
Table 81: Neovasc Files Registration Statement For Public Offering Of Securities For Up To US$200 Million 184
Table 82: Neovasc Completes Public Offering Of Shares For US$22.7 Million 185
Table 83: CardioComm Solutions Completes First Tranche Of Private Placement For US$0.1 Millon 186
Table 84: Neovasc Completes Private Placement Of Shares For US$2.2 Million Upon Exercise Of Warrants 187
Table 85: Abiomed Enters Into Licensing Agreement With Opsens For Optical Sensor Technology 189
Table 86: QHR Technologies Enters Into Agreement With Welch Allyn For Cardiopulmonary Devices 190
Table 87: Interface Biologics To Enter Into Co-Development Agreement With Qualimed Innovative Medizinprodukte 191
Table 88: Koninklijke Royal Philips And Infraredx Enter Into Agreement For Imaging System And X-ray Systems 192
Table 89: Xenios Enters Into Licensing Agreement With Leukocare For Next Generation Extracorporeal Support Systems 193
Table 90: AngioDynamics Extends Licensing Agreement With Interface Biologics To Include Central Venous Catheters 194
Table 91: Terumo Enters Into Co-Development Agreement With Kaneka For PTA Balloon Catheters 196
Table 92: Terumo Enters Into Agreement With Shanghai AngioCare Medical Technolgy 197
Table 93: NeoChord Enters Into Licensing Agreement With Robarts Research Institute 198
Table 94: Biosensors Extends Licensing Agreement With Terumo For BioMatrix Technology 199
Table 95: CellAegis Devices Raises Funds Through Venture Financing 200
Table 96: CellAegis Devices Raises US$0.02 Million In Venture Financing 201
Table 97: Total Number of Primary Research Participants, Cardiovascular Devices Market, by Country 242

1.2 List of Figures
Figure 1: Cardiovascular Devices Market, Canada, Revenue ($m), USD Constant, 2005-2020 32
Figure 2: Cardiovascular Devices Market, Canada, Revenue Mix ($m), 2012 34
Figure 3: Cardiovascular Devices Market, Canada, Category Contribution (%), 2012 35
Figure 4: Cardiovascular Devices Market, Canada, Category Comparison by Revenue ($m), 2005-2020 37
Figure 5: Cardiovascular Devices Market, Canada, Revenue ($m), USD Constant, Historic, 2005-2012 39
Figure 6: Cardiovascular Devices Market, Canada, Revenue ($m), USD Constant, Forecast, 2012-2020 41
Figure 7: Cardiovascular Devices Market, Canada, Volume (Units), 2005-2020 43
Figure 8: Cardiovascular Devices Market, Canada, Volume (Units), Historic, 2005-2012 45
Figure 9: Cardiovascular Devices Market, Canada, Volume (Units), Forecast, 2012-2020 47
Figure 10: Cardiovascular Devices Market, Canada, Company Share (%), 2012 50
Figure 11: Cardiac Assist Devices Market, Canada, Revenue Mix ($m), 2012 52
Figure 12: Cardiac Assist Devices Market, Canada, Segment Contribution (%), 2012 53
Figure 13: Cardiac Assist Devices Market, Canada, Revenue ($m), USD Constant, Historic, 2005-2012 54
Figure 14: Cardiac Assist Devices Market, Canada, Revenue ($m) USD Constant, Forecast, 2012-2020 56
Figure 15: Cardiac Assist Devices Market, Canada, Volume (Units), Historic, 2005-2012 58
Figure 16: Cardiac Assist Devices Market, Canada, Volume (Units), Forecast, 2012-2020 60
Figure 17: Cardiac Assist Devices Market, Canada, Company Share (%), 2012 63
Figure 18: Cardiac Rhythm Management Market, Canada, Revenue Mix ($m), 2012 65
Figure 19: Cardiac Rhythm Management Market, Canada, Segment Contribution (%), 2012 66
Figure 20: Cardiac Rhythm Management Market, Canada, Revenue ($m), USD Constant, Historic, 2005-2012 67
Figure 21: Cardiac Rhythm Management Market, Canada, Revenue ($m) USD Constant, Forecast, 2012-2020 69
Figure 22: Cardiac Rhythm Management Market, Canada, Volume (Units), Historic, 2005-2012 71
Figure 23: Cardiac Rhythm Management Market, Canada, Volume (Units), Forecast, 2012-2020 73
Figure 24: Cardiac Rhythm Management Market, Canada, Company Share (%), 2012 76
Figure 25: Cardiovascular Monitoring and Diagnostic Devices Market, Canada, Revenue ($m), USD Constant, Historic, 2005-2012 78
Figure 26: Cardiovascular Monitoring and Diagnostic Devices Market, Canada, Revenue ($m) USD Constant, Forecast, 2012-2020 80
Figure 27: Cardiovascular Monitoring and Diagnostic Devices Market, Canada, Volume (Units), Historic, 2005-2012 82
Figure 28: Cardiovascular Monitoring and Diagnostic Devices Market, Canada, Volume (Units), Forecast, 2012-2020 83
Figure 29: Cardiovascular Monitoring and Diagnostic Devices Market, Canada, Company Share (%), 2012 85
Figure 30: Cardiovascular Prosthetic Devices Market, Canada, Revenue Mix ($m), 2012 87
Figure 31: Cardiovascular Prosthetic Devices Market, Canada, Segment Contribution (%), 2012 88
Figure 32: Cardiovascular Prosthetic Devices Market, Canada, Revenue ($m), USD Constant, Historic, 2005-2012 89
Figure 33: Cardiovascular Prosthetic Devices Market, Canada, Revenue ($m) USD Constant, Forecast, 2012-2020 91
Figure 34: Cardiovascular Prosthetic Devices Market, Canada, Volume (Units), Historic, 2005-2012 93
Figure 35: Cardiovascular Prosthetic Devices Market, Canada, Volume (Units), Forecast, 2012-2020 95
Figure 36: Cardiovascular Prosthetic Devices Market, Canada, Company Share (%), 2012 98
Figure 37: Cardiovascular Surgery Market, Canada, Revenue Mix ($m), 2012 100
Figure 38: Cardiovascular Surgery Market, Canada, Segment Contribution (%), 2012 101
Figure 39: Cardiovascular Surgery Market, Canada, Revenue ($m), USD Constant, Historic, 2005-2012 102
Figure 40: Cardiovascular Surgery Market, Canada, Revenue ($m) USD Constant, Forecast, 2012-2020 104
Figure 41: Cardiovascular Surgery Market, Canada, Volume (Units), Historic, 2005-2012 106
Figure 42: Cardiovascular Surgery Market, Canada, Volume (Units), Forecast, 2012-2020 108
Figure 43: Cardiovascular Surgery Market, Canada, Company Share (%), 2012 111
Figure 44: Electrophysiology Market, Canada, Revenue Mix ($m), 2012 113
Figure 45: Electrophysiology Market, Canada, Segment Contribution (%), 2012 114
Figure 46: Electrophysiology Market, Canada, Revenue ($m), USD Constant, Historic, 2005-2012 115
Figure 47: Electrophysiology Market, Canada, Revenue ($m) USD Constant, Forecast, 2012-2020 117
Figure 48: Electrophysiology Market, Canada, Volume (Units), Historic, 2005-2012 119
Figure 49: Electrophysiology Market, Canada, Volume (Units), Forecast, 2012-2020 121
Figure 50: Electrophysiology Market, Canada, Company Share (%), 2012 124
Figure 51: External Defibrillators Market, Canada, Revenue ($m), USD Constant, Historic, 2005-2012 126
Figure 52: External Defibrillators Market, Canada, Revenue ($m) USD Constant, Forecast, 2012-2020 127
Figure 53: External Defibrillators Market, Canada, Volume (Units), Historic, 2005-2012 128
Figure 54: External Defibrillators Market, Canada, Volume (Units), Forecast, 2012-2020 129
Figure 55: External Defibrillators Market, Canada, Company Share (%), 2012 131
Figure 56: Interventional Cardiology Market, Canada, Revenue Mix ($m), 2012 133
Figure 57: Interventional Cardiology Market, Canada, Segment Contribution (%), 2012 134
Figure 58: Interventional Cardiology Market, Canada, Revenue ($m), USD Constant, Historic, 2005-2012 135
Figure 59: Interventional Cardiology Market, Canada, Revenue ($m) USD Constant, Forecast, 2012-2020 137
Figure 60: Interventional Cardiology Market, Canada, Volume (Units), Historic, 2005-2012 139
Figure 61: Interventional Cardiology Market, Canada, Volume (Units), Forecast, 2012-2020 141
Figure 62: Interventional Cardiology Market, Canada, Company Share (%), 2012 144
Figure 63: Peripheral Vascular Devices Market, Canada, Revenue Mix ($m), 2012 146
Figure 64: Peripheral Vascular Devices Market, Canada, Segment Contribution (%), 2012 147
Figure 65: Peripheral Vascular Devices Market, Canada, Revenue ($m), USD Constant, Historic, 2005-2012 149
Figure 66: Peripheral Vascular Devices Market, Canada, Revenue ($m) USD Constant, Forecast, 2012-2020 151
Figure 67: Peripheral Vascular Devices Market, Canada, Volume (Units), Historic, 2005-2012 153
Figure 68: Peripheral Vascular Devices Market, Canada, Volume (Units), Forecast, 2012-2020 155
Figure 69: Peripheral Vascular Devices Market, Canada, Company Share (%), 2012 158
Figure 70: Prosthetic Heart Valves Market, Canada, Revenue Mix ($m), 2012 160
Figure 71: Prosthetic Heart Valves Market, Canada, Segment Contribution (%), 2012 161
Figure 72: Prosthetic Heart Valves Market, Canada, Revenue ($m), USD Constant, Historic, 2005-2012 162
Figure 73: Prosthetic Heart Valves Market, Canada, Revenue ($m) USD Constant, Forecast, 2012-2020 164
Figure 74: Prosthetic Heart Valves Market, Canada, Volume (Units), Historic, 2005-2012 166
Figure 75: Prosthetic Heart Valves Market, Canada, Volume (Units), Forecast, 2012-2020 168
Figure 76: Prosthetic Heart Valves Market, Canada, Company Share (%), 2012 171
Figure 77: GlobalData Epidemiology-Based Forecasting Model 244
Figure 78: GlobalData Capital Equipment-Based Forecasting Model 245

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Transplant Diagnostics: Technologies and Global Markets

Transplant Diagnostics: Technologies and Global Markets

  • $ 6650
  • Industry report
  • October 2016
  • by BCC Research

Use this report to: - Identify key market segments - Gain insight into the trends, gaps, and opportunities in each of the micro markets. - Learn about the key market dynamics and the factors impacting ...

EU5 Ultrasound Systems Market Outlook to 2022

EU5 Ultrasound Systems Market Outlook to 2022

  • $ 5995
  • Industry report
  • February 2017
  • by GlobalData

EU5 Ultrasound Systems Market Outlook to 2022 Summary GlobalData’s new report, "EU5 Ultrasound Systems Market Outlook to 2022", provides key market data on the EU5 Ultrasound Systems market. The report ...

North America Magnetic Resonance Imaging (MRI) Systems Market Outlook to 2022

North America Magnetic Resonance Imaging (MRI) Systems Market Outlook to 2022

  • $ 5995
  • Industry report
  • February 2017
  • by GlobalData

North America Magnetic Resonance Imaging (MRI) Systems Market Outlook to 2022 Summary GlobalData’s new report, "North America Magnetic Resonance Imaging (MRI) Systems Market Outlook to 2022", provides ...


ref:plp2014

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.